Nature Reviews Endocrinology

Article	Citations
The largest study of genetics of T1DM	531
A protective role for insulin in acute pancreatitis	506
Nonenzymatic prevention of insulin hyperresponsiveness by FBP1	479
Anti-PIT1 hypophysitis after immune checkpoint inhibitor treatment	454
Increasing success of islet transplantation	320
CNOT6L regulates hepatokine expression	312
The relationship between the gut microbiota and thyroid disorders	308
FAPs linked with muscle degeneration in T2DM	301
Glycogen involved in browning of adipocytes	287
Ageing immune cells reduce adipose tissue function	286
Aster pathway maintains hepatic cholesterol homeostasis	257
A role for circulating levels of uridine in regulating hunger and food intake	257
Differences in stem cell-derived islets	240
Ghrelin’s effects on growth hormone release: to pulse or not to pulse?	238
Dexamethasone in patients with diabetes mellitus	210
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations	198
Memory of obesity stored in adipocytes	152
Immune cell population prevents weight regain	149
GWAS gives insights into glucose regulation	147
Exercise-induced plasma factors confer brain benefits	146
Fetal orchestration of maternal metabolism via IGF2	139
Caution needed: paracetamol use in pregnancy	137
Phase IIa results for potential NAFLD therapy	130
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice	129
Exposing skin to ultraviolet irradiation increases food intake in male individuals	124

Interventions in people newly diagnosed with type 1 diabetes mellitus	119
Origins of the ‘KNDy hypothesis’ of GnRH pulse generation	113
Bile acid species shows potential for NAFLD	113
Low brown adipose tissue activity linked to NAFLD	111
A century of glucagon	109
Obesity-associated ASB4 controls satiety	107
Mitochondria transported from adipocytes in extracellular vesicles	107
Non-nutritive sweeteners — too sweet to be wholesome?	106
Uncovering how the GnRH pulse generator is controlled in female mice	106
Effects of diet on atherosclerotic plaque development	106
Timed high-fat diet feeding restores small bowel circadian rhythms	100
Unravelling the molecular basis of futile creatine cycling	99
A mitochondrial trigger for beige adipocyte development	97
Adrenal cysts: an emerging condition	96
The enduring relevance of the Randle cycle	95
New insights on regulatory T cell decline in obesity	93
Exploring the functions of the myokine feimin	93
The complexity of adipocyte heterogeneity	91
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia	88
Statins and diabetes mellitus progression: a fly in the ointment?	87
Identification of thermogenic adipocyte lineages	86
New genes associated with adult-onset obesity	83
Phospholipid biosynthetic pathways and lipodystrophies: a novel syndrome due to PLAAT3 deficiency	82
Metabolic control of puberty: 60 years in the footsteps of Kennedy and Mitra’s seminal work	79
TIM4+ adipose tissue-resident macrophages: new modulators of adiposity	78
PPAR mediates intestinal stem cell tumorigenesis	76
Liver–bone crosstalk implicated in osteoporosis progression	72
CITED1 mediates sex-specific regulation of food intake in hypothalamic neurons	72
Brain–immune networks: a role for GLP1 receptor	71
A perspective on treating type 1 diabetes mellitus before insulin is needed	71
Do psychedelics have therapeutic potential for obesity?	69
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer	67
The role of DNA damage in diabetic complications	66
Diagnosis of gestational diabetes mellitus: the debate continues	66
Co-agonist therapeutics come of age for obesity	66
Thyroid function and iodine intake: global recommendations and relevant dietary trends	65
The influence of the circulatory system on tissue ageing: does the fountain of youth lie in our blood?	65
Medically not yet explained symptoms in hypothyroidism	63
Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus	61
Paracetamol use in pregnancy — caution over causal inference from available data	59
Machine intelligence in non-invasive endocrine cancer diagnostics	58
Reply to ‘Paracetamol use in pregnancy — neglecting context promotes misinterpretation’	56
Is combined exercise and incretin-based therapy the way forward for weight-loss maintenance?	50
On the cutting edge: perspectives in bioenergetics	50
Non-invasive daily profiles of tissue adrenal steroids	50
The discovery of human monogenic obesity	49
Urban built environments: interventions for reducing cardiometabolic risks	49
Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss	48
SGLT inhibitors: a serendipitous glycaemic tale	48
Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement	46

The challenges of assessing adiposity in a clinical setting	45
Lactate as a major myokine and exerkine	43
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy	43
Adipose tissue lipolysis controlled by endothelial cells	42
Limiting the use and misuse of liothyronine in hypothyroidism	42
Highlights from the Joint Irish–UK Endocrine Meeting 2024	40
Author Correction: Growth hormone-releasing hormone and its analogues in health and disease	40
Highlights from SfE BES 2021	40
The epidemiology of type 1 diabetes mellitus in older adults	40
Neutrophils might link intestinal damage to retinopathy in type 2 diabetes mellitus	39
Brown adipose tissue fights the battle against leukaemia	39
Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults	39
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases	38
The individual response to antibiotics and diet — insights into gut microbial resilience and host metabolism	38
Is calorie labelling on menus the solution to obesity?	36
Approaches to addressing the rise in obesity levels	36
Programming of metabolism by adipokines during development	36
Heterogeneity and endotypes in type 1 diabetes mellitus	34
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment	33
Strategies for modelling endometrial diseases	32
The regulation of endocrine-disrupting chemicals to minimize their impact on health	32
Harnessing the inflammatory processes in endometriosis	32
Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia	31
The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action	31
The gut microbiota in obesity and weight management: microbes as friends or foe?	31
Obesity-induced and weight-loss-induced physiological factors affecting weight regain	29
Type 2 diabetes mellitus in older adults: clinical considerations and management	28
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead	28
Exerkines in health, resilience and disease	27
Autocrine FGF21 signalling promotes beiging	26
Variation in metformin pharmacokinetics	26
Succinate signalling regulates leptin production in adipocytes	26
To fast or not to fast — that is the question	26
Exploring the regulation of glucagon secretion	25
Cause of rare form of Cushing syndrome found	25
New treatment target for endometriosis	25
Syntaxin 4 — protective in β-cells in T1DM?	25
Hepatic T helper 17 cells implicated in NAFLD	24
Feasibility and effectiveness of time-restricted eating in different populations	24
Role for IL-17A in adipocyte biology	24
Obesity phenotypes: explaining the unexplained	23
Functional HNF1A variants linked with T2DM risk in European-ancestry populations	23
Metabolite levels during the menstrual cycle	22
Lipidomics reveals early markers	22
Brain insulin action in women	22
Neurons in the diagonal band of Broca moderate food intake	21
Insulin receptor sets liver clock	21
Female-specific inflammatory signalling exacerbates central nervous system autoimmunity in obesity	20
Ketosis improves muscle stem cell resilience	19
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health	18
Optimising stem cells for diabetes mellitus therapy	17
Lactation duration affects obesity risk in rat offspring	17
Iron in adipocytes — a role in gut–adipose crosstalk	17
Negative regulator of GDF15 signalling identified	16
Antivirals in the treatment of new-onset T1DM	16
Defining subpopulations of human adipose tissue progenitor cells	16
SRC2 controls the refeeding response in mice	16
New mechanism of Cushing disease revealed	16
Function of a common FTO variant in vivo	14
Precision medicine approach improves HbA1c outcomes in T2DM	14
Metformin reduces ageing adipose senescence	14
Role for exosomes in insulin sensitivity	14
Engineering stem cells to recapitulate thyroid cancer	14
Opposing neuropeptides control cAMP signalling to regulate satiety	13
Osteal macrophages implicated in osteoporosis	13
PDL1 reduces adipose inflammation in obesity	13
Post-burn endocrine–immune dynamics and ageing considerations	13
The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease	13
DDIT4 contributes to macrophage reprogramming	13
Novel therapies with precision mechanisms for type 2 diabetes mellitus	13
Sex differences in diabetic kidney disease explained	13
Probing α-cell dysfunction in type 2 diabetes mellitus	13
Health equity in endocrinology	12
How COVID-19 disrupts glycometabolic control	12
Advances in the management of achondroplasia	12
Combination therapy increases human β-cell mass in vivo	12
High-intensity exercise training — too much of a good thing?	12
Endocrinology in the multi-omics era	12
Author Correction: Optoacoustic imaging in endocrinology and metabolism	12
Research in metabolic ageing — a tale of mice versus humans?	11

The interactions between energy homeostasis and neurovascular plasticity	11
Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus	11
Knowledge in youth is wisdom in age: involving young people in research	11